I may add more to this post later, but for now check out this excellent new Replicel CEO interview. Mr. David Hall essentially seems to be claiming that this is a complete cure once the main challenges regarding dosage and frequency are resolved. I may have to change my opinion about Histogen’s recent presentation suggesting superior results to Replicel.
If you live anywhere near San Diego (now one of the world’s leading biotech hubs), the “Stem Cell Meeting on the Mesa” from October 7-9, 2014 is worth attending if you can somehow get in. Surprisingly, both Histogen (based in San Diego) and Replicel (based in Vancouver, Canada) are presenting at this event. For more, scroll all the way down on this detailed descriptions page of each company’s presentation. Histogen’s presentation will be given by CEO Gail Naughton and Replicel’s presentation will be given by CEO David Hall. I wonder if these two competitors will talk to each other at lunch?
I do not expect either company’s hair loss research related presentation to divulge anything new or ground breaking. However, the overall conference is extremely interesting in terms of the incredible advances that are now being made in regenerative medicine, gene therapy, stem cell research and more. Many of the speakers are renowned leaders in their fields.
An interesting recent article on Replicel.